The National Association of Boards of Pharmacy (NABP) and the Anti-Diversion Industry Working Group (ADIWG), a consortium of pharmaceutical manufacturers and distributors, has created this educational video for pharmacists to help them identify the warning signs of prescription drug abuse and diversion when dispensing controlled substance prescriptions.
The Drug Enforcement Administration (DEA) and various state pharmacy boards describe red flags as circumstances that should raise reasonable suspicion about the validity of a controlled substance prescription. The video highlights a number of these potential warning signs, some which are not easy to spot, by weaving personal narratives with interactions between pharmacists and customers.
Red Flags is sponsored by six ADIWG member companies - the group's founder, Mallinckrodt Pharmaceuticals, along with members, Cardinal Health, McKesson Corporation, AmerisourceBergen, Actavis and Endo-Qualitest Pharmaceuticals - as part of the group's commitment to reduce prescription drug diversion and abuse. This is the first educational tool produced by the ADIWG as it continues its collaborative effort to help combat America's fastest growing drug problem.